Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against <i>Candida albicans</i>

Luliconazole is a new topical imidazole antifungal drug for the treatment of skin infections. It has low solubility and poor skin penetration which limits its therapeutic applications. In order to improve its therapeutic efficacy, spanlastics nanoformulation was developed and optimized using a combi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Nabil A. Alhakamy, Mohammed W. Al-Rabia, Shadab Md, Alaa Sirwi, Selwan Saud Khayat, Sahar Saad AlOtaibi, Raghad Abkar Hakami, Hadeel Al Sadoun, Basmah Medhat Eldakhakhny, Wesam H. Abdulaal, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, Mahmoud A. Elfaky
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2021-06-01
סדרה:	Pharmaceutics
נושאים:	luliconazole spanlastics particle size <i>Candida albicans</i> infections lesion score
גישה מקוונת:	https://www.mdpi.com/1999-4923/13/7/977
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!